ALEMBIC PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 Nov 2022
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg.
Source:
BSE India